Ursolic acid against prostate and urogenital cancers: a review of in vitro and in vivo studies
Prostate cancer is the second most diagnosed form of cancer in men worldwide and
accounted for roughly 1.3 million cases and 359,000 deaths globally in 2018, despite all the …
accounted for roughly 1.3 million cases and 359,000 deaths globally in 2018, despite all the …
VAV3 in human cancers: Mechanism and clinical implication
Guanine nucleotide exchange factors (GEFs) are primarily involved in signal transmission
between cell membrane receptors and intracellular mediators. Upon replacing GDP with …
between cell membrane receptors and intracellular mediators. Upon replacing GDP with …
Development of novel paclitaxel-loaded ZIF-8 metal-organic framework nanoparticles modified with peptide dimers and an evaluation of its inhibitory effect against …
H Zhao, L Gong, H Wu, C Liu, Y Liu, C Xiao, C Liu… - Pharmaceutics, 2023 - mdpi.com
Prostate cancer (PC) is one of the common malignant tumors of the male genitourinary
system. Here, we constructed PTX@ ZIF-8, which is a metal-organic-framework …
system. Here, we constructed PTX@ ZIF-8, which is a metal-organic-framework …
[HTML][HTML] Bromocriptine monotherapy overcomes prostate cancer chemoresistance in preclinical models
L Bai, X Li, Y Yang, R Zhao, EZ White, A Danaher… - Translational …, 2023 - Elsevier
Chemoresistance is a major obstacle in the clinical management of metastatic, castration-
resistant prostate cancer (PCa). It is imperative to develop novel strategies to overcome …
resistant prostate cancer (PCa). It is imperative to develop novel strategies to overcome …
Overexpressed KCNK1 regulates potassium channels affecting molecular mechanisms and biological pathways in bladder cancer
W Zhang, XS Chen, Y Wei, XM Wang, XJ Chen… - European Journal of …, 2024 - Springer
This study aimed to explore the expression, molecular mechanism and its biological function
of potassium two pore domain channel subfamily K member 1 (KCNK1) in bladder cancer …
of potassium two pore domain channel subfamily K member 1 (KCNK1) in bladder cancer …
Discovery and biological evaluation of novel CARM1/HDAC2 dual-targeting inhibitors with anti-prostate cancer agents
S Liang, Y Geng, MM Niu, Y Zhang, W He… - Journal of Enzyme …, 2023 - Taylor & Francis
Prostate cancer (PCa) is a clinically heterogeneous disease with a progressively increasing
incidence. Concurrent inhibition of coactivator-associated arginine methyltransferase 1 …
incidence. Concurrent inhibition of coactivator-associated arginine methyltransferase 1 …
Targeting sphingosine 1-phosphate metabolism as a therapeutic avenue for prostate cancer
S Mebarek, N Skafi, L Brizuela - Cancers, 2023 - mdpi.com
Simple Summary Prostate cancer (PC) is the most common cancer in men over 65 and the
fifth leading cause of death by cancer in men. Sphingosine 1-phosphate (S1P) is a bioactive …
fifth leading cause of death by cancer in men. Sphingosine 1-phosphate (S1P) is a bioactive …
Novel FOXM1 inhibitor STL001 sensitizes human cancers to a broad-spectrum of cancer therapies
S Raghuwanshi, X Zhang, Z Arbieva, I Khan… - Cell Death …, 2024 - nature.com
Forkhead box protein M1 (FOXM1) is often overexpressed in human cancers and strongly
associated with therapy resistance and less good patient survival. The chemotherapy …
associated with therapy resistance and less good patient survival. The chemotherapy …
Development and characterisation of suitably bioengineered microfibrillar matrix-based 3D prostate cancer model for in vitro drug testing
AT Thilakan, N Nandakumar… - Biomedical …, 2023 - iopscience.iop.org
Bioengineered 3D models that can mimic patient-specific pathologies in vitro are valuable
tools for developing and validating anticancer therapeutics. In this study, microfibrillar …
tools for developing and validating anticancer therapeutics. In this study, microfibrillar …
Hippo signaling modulation and its biological implications in urological malignancies
T Tong, M Huang, B Yan, B Lin, J Yu, Q Teng… - Molecular Aspects of …, 2024 - Elsevier
Although cancer diagnosis and treatment have rapidly advanced in recent decades,
urological malignancies, which have high morbidity and mortality rates, are among the most …
urological malignancies, which have high morbidity and mortality rates, are among the most …